Form 4: Zimmer Biomet Director Farrell Reports Acquisition of Phantom Stock Units

Director Michael J. Farrell reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• On June 30, 2024, Michael J. Farrell, a director of Zimmer Biomet Holdings, Inc., acquired 299.594 phantom stock units under the company's Deferred Compensation Plan for Non-Employee Directors.
• The price of the derivative security is $0.
• These units are to be settled in cash in a lump sum within sixty days after Farrell's service as a director ends.
• Following the reported transaction, Farrell beneficially owns 14,586.221 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices for directors, aligning their interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The Deferred Compensation Plan for Non-Employee Directors is a common practice to attract and retain qualified board members.

Future Outlook

The phantom stock units will be settled in cash within sixty days after cessation of the reporting person's service as a Director.

Industry Context

The granting of phantom stock units to non-employee directors is a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term value creation.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively influence shareholder confidence by aligning management's interests with those of the shareholders.

Key Dates